Week 40: Momentum Moves—Sold HUM, Added to ELF & HALO (40 / 2026)


Market Signal: Green

Between no buys and 1 sell, this week added up to 1 trade.

As usual, the full ranking for week 40 is posted here.

Ranking

Disclaimer

This week, our trading activity was guided by the prevailing market tone with the S&P 500 trading above its 200-day moving avereage for 122 days—still good conditions for momentum investing according to the regime filter we use, inspired by Andreas Clenow’s ‘Stocks on the Move’. Notably, yesterday the 10-year US Treasury yield reached 5.25%, resulting in some hesitancy in equities, although the VIX remains calm, suggesting no major panic. As a precaution, we closed our position in Humana (HUM) while adding to our existing investments in ELF and HALO. With the market showing mixed signals, one might wonder when investors will start locking in yields for the long term.

Our portfolio adjustments this week were straightforward. We sold Humana, a major health insurance provider, as it no longer fits our criteria for top momentum stocks. On the flip side, we added to our positions in e.l.f. Beauty (ELF), known for its cosmetics, and Halozyme Therapeutics (HALO), which specializes in drug delivery solutions. These enhancements were made as part of our weekly momentum trades, an essential aspect of our strategy.

The Healthcare sector stood out as the week’s top sector for us, with its typical stability playing a key role in our investment lineup. Updates in our ranks see Halozyme (HALO) and Haemonetics (HAE), in the blood management solutions space, leading the charge. Park Hotels & Resorts (PK) also remains strong in our portfolio. On the performance front, our portfolio is modestly ahead of the SPY, finishing the week up by 2.8% compared to SPY’s 0.3% return. Top performers included Illumina (ILMN), which gained 13.9%, and Snow Software (SN) at 8.9%. Meanwhile, Dell Technologies (DELL) and Haemonetics (HAE) experienced some downturns. Our model ranks Moderna (MRNA), PBF Energy (PBF), and others favorably, although they’re not in the current holdings.

Feel free to share your thoughts or queries on these trades in the comments below!

This week’s transactions:

  • Sold:

  • Bought:

    • No buys in this week!
  • Rebalanced / added:

  • Rebalanced / reduced:

    • No positions were reduced in this week!



Index Distribution:

Currently, most stocks of the portfolio are coming from the S&P 400:



Current portfolio allocation:

The Healthcare sector now has the largest share in the portfolio:



Weekly sector distribution:



Current portfolio (@finviz):

Symbol Name Index Sector MC Dist to 52w High pct
PK Park Hotels & Resorts Inc S&P 400 Real Estate 3.13B -3.89% 0.078
HALO Halozyme Therapeutics Inc S&P 400 Healthcare 12.66B -4.52% 0.073
HAE Haemonetics Corp S&P 400 Healthcare 4.81B -4.21% 0.065
CRL Charles River Laboratories International Inc S&P 500 Healthcare 14.13B -2.42% 0.064
NTNX Nutanix Inc S&P 400 Technology 18.96B -10.66% 0.062
ILMN Illumina Inc S&P 500 Healthcare 41.07B -2.14% 0.062
AVTR Avantor Inc S&P 400 Healthcare 10.31B -5.05% 0.056
VEEV Veeva Systems Inc S&P 500 Healthcare 45.10B -10.28% 0.053
FTNT Fortinet Inc S&P 500 Technology 129.10B -2.98% 0.048
NTAP Netapp Inc S&P 500 Technology 41.09B 0.06% 0.048
ELF e.l.f. Beauty Inc S&P 400 Consumer Defensive 6.00B -31.17% 0.046
OKTA Okta Inc S&P 400 Technology 35.82B -3.59% 0.044
DELL Dell Technologies Inc S&P 500 Technology 343.08B -9.39% 0.039
PBF PBF Energy Inc S&P 400 Energy 8.92B -8.93% 0.039
ANF Abercrombie & Fitch Co S&P 400 Consumer Cyclical 5.67B -13.94% 0.038
HPE Hewlett Packard Enterprise Co S&P 500 Technology 81.63B -6.34% 0.037
QLYS Qualys Inc S&P 400 Technology 6.17B -11.51% 0.036
PANW Palo Alto Networks Inc S&P 500 Technology 317.72B -2.62% 0.028
BAX Baxter International Inc S&P 500 Healthcare 12.14B -21.73% 0.028
SN SharkNinja Inc S&P 400 Consumer Cyclical 25.70B -6.22% 0.026
CRWD Crowdstrike Holdings Inc S&P 500 Technology 269.03B -0.43% 0.022
cash Cash Cash Cash – - 0.009

As always, more trades next week!

CW40  2026 

See also

Privacy Policy